Abiopharma

News list

Duchscher Robert 🟡 adjusted position in 2.7K shares (1 derivative) of SunOpta Inc. (STKL) at $6.48 Transaction Date: Apr 11, 2026 | Filing ID: 000069

Full text

News bot April 15, 2026, 1:22 a.m.
🔍 Duchscher Robert (Executive)

Company: SunOpta Inc. (STKL)

Report Date: 2026-04-11
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 5,538
- Total shares sold: 8,263
Detailed Transactions and Holdings:
- Acquired 5,538 shares of Common Shares (Direct)
  Date: 2026-04-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 26,785.00 | transaction_form_type: 4 | Footnotes: F1
- Sold 2,725 shares of Common Shares at $6.48 per share (Direct)
  Date: 2026-04-11 | Code: F | equity_swap_involved: 0 | shares_owned_after: 24,060.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 5,538 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,075.00 | transaction_form_type: 4 | Footnotes: F1, F3, F4
Footnotes:
- F1: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
- F2: This line item reflects the deemed disposition of shares withheld by the Company to satisfy income tax withholding requirements in connection with the vesting of the RSUs.
- F3: The Restricted Stock Units vest in three equal annual installments beginning on April 11, 2026, subject to the continued employment of the reporting person through each such vesting date.
- F4: The Restricted Stock Units do not have an expiration date.